Europe - Euronext Paris - EPA:EQS - FR0012882389 - Common Stock
We assign a fundamental rating of 6 out of 10 to EQS. EQS was compared to 11 industry peers in the Health Care Technology industry. EQS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EQS has a decent growth rate and is not valued too expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 15.77% | ||
| ROIC | 12.84% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.02% | ||
| PM (TTM) | 16.13% | ||
| GM | 68.81% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Altman-Z | 3.87 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.96 | ||
| Fwd PE | 12.85 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.55 | ||
| EV/EBITDA | 8.25 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.07% |
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.
ChartMill assigns a valuation rating of 6 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.
EQUASENS (EQS.PA) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for EQUASENS (EQS.PA) is 16.96 and the Price/Book (PB) ratio is 2.68.
The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 13% in the next year.